Form CORRESP - Correspondence:
SEC Accession No. 0001683168-24-004012
Filing Date
2024-06-06
Accepted
2024-06-06 08:01:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7839
  Complete submission text file 0001683168-24-004012.txt   9103
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)